Abstract
Development of the Tablet Dosage Form Composition for the Inductor of Hepatocytes Monooxygenase System Based on 6,8-dimethyl-2-piperidinomethyl-2,3-dihydrothiazolo[2,3-F]xanthine
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have